Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) Short Interest Up 215.7% in April

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY - Get Free Report) was the target of a significant growth in short interest in April. As of April 15th, there was short interest totalling 90,300 shares, a growth of 215.7% from the March 31st total of 28,600 shares. Approximately 0.0% of the shares of the stock are sold short. Based on an average daily volume of 165,800 shares, the days-to-cover ratio is currently 0.5 days.

Analyst Ratings Changes

Separately, Deutsche Bank Aktiengesellschaft restated a "buy" rating on shares of Fresenius SE & Co. KGaA in a research report on Monday, February 3rd.

Fresenius SE & Co. KGaA Price Performance

Shares of Fresenius SE & Co. KGaA stock traded down $0.04 during trading hours on Friday, hitting $11.39. The company's stock had a trading volume of 19,473 shares, compared to its average volume of 61,275. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.05 and a current ratio of 1.36. Fresenius SE & Co. KGaA has a 12-month low of $7.30 and a 12-month high of $11.56. The business has a 50 day moving average price of $10.64 and a two-hundred day moving average price of $9.65. The company has a market cap of $25.45 billion, a PE ratio of 54.24 and a beta of 0.86.

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY - Get Free Report) last released its quarterly earnings data on Wednesday, February 26th. The company reported $0.18 earnings per share (EPS) for the quarter. The company had revenue of $6.01 billion for the quarter. Analysts expect that Fresenius SE & Co. KGaA will post 0.79 earnings per share for the current fiscal year.

Fresenius SE & Co. KGaA Company Profile

Fresenius SE & Co KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.